CAS RN: 1711-61-1
1,3,4-Oxadiazol-2(3H)-one, 5-(4-chlorophenyl)-
Product Availability
Choose a grade to view its available package options.
1 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20251013 |
100mg / 250mg / 1g / 5g |
Confirm by inquiry |
Shanghai | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g, 5g
- Available purity: >97%
- Inventory rows with stock: 8
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1711-61-1
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
-- |
1
In Stock
|
Shenzhen |
Inquiry |
| 0.1g |
>97% |
1
In Stock
|
Shenzhen |
Inquiry |
| 0.25g |
-- |
1
In Stock
|
Beijing |
Inquiry |
| 0.25g |
>97% |
1
In Stock
|
Hong Kong |
Inquiry |
| 1g |
-- |
1
In Stock
|
Beijing |
Inquiry |
| 1g |
>97% |
1
In Stock
|
Beijing |
Inquiry |
| 5g |
-- |
1
In Stock
|
Beijing |
Inquiry |
| 5g |
>97% |
1
In Stock
|
Hong Kong |
Inquiry |
1711-61-1 / 5-(4-chlorophenyl)-3H-1,3,4-oxadiazol-2-one
Standard CAS: 1711-61-1
Multi CAS: No
Basic Information
CAS
1711-61-1
Multi CAS
No
Molecular Formula
C8H5ClN2O2
Molecular Weight
196.590000
Exact Mass
196.003955
SMILES
C1=CC(=CC=C1C2=NNC(=O)O2)Cl
InChI
InChI=1S/C8H5ClN2O2/c9-6-3-1-5(2-4-6)7-10-11-8(12)13-7/h1-4H,(H,11,12)
InChIKey
IBXCIADJXVFGAL-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
13
Aromatic heavy atom count
11
Rotatable bonds
1
H-bond acceptors
3
H-bond donors
1
Molar refractivity
47.57
TPSA
58.89
LogP / Solubility
WLOGP
1.68
MLOGP
1.48
XLogP3
2.1
Consensus LogP
1.75
Log S (ESOL)
-2.68
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.39
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.45
Class (SILICOS-IT)
Moderately soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.72
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5
Safety & Transport
Pictogram(s)
Irritant
Signal
Warning
GHS Hazard Statements
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
Precautionary Statement Codes
P264, P270, P301+P317, P330, and P501